OpenAlex
PricingAboutJobs
Log inGet started
Work

Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study

HTML

Year: 2002
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2002.02.051
Authors: Ronald Bukowski, Marc S. Ernstoff, Martin E. Gore, John J. Nemunaitis, Robert Amato, Samir K. Gupta, Craig L. Tendler
Institutions: Dartmouth–Hitchcock Medical Center, Cleveland Clinic, Texas Medical Center, Baylor College of Medicine, Royal Marsden Hospital, Dartmouth Cancer Center
Language: English

Topic: Renal cell carcinoma treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: peginterferon alfa-2b, renal cell carcinoma, advanced solid tumors, maximum tolerated dose, safety and tolerability, hematologic toxicity, objective response rate, metastatic cancer, antitumor efficacy
SDG: Good health and well-being

Open Access status: closed

Funder: Roche
OpenAlex ID: W1967708299
FWCI: 4.877
Cites: 27
Cited by: 121
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security